CDC warns hospitals about drug-resistant 'superbug'
Government officials want the nation's health care providers to step up efforts to halt the spread of a drug-resistant "nightmare bacteria" that attacks the bloodstream and kills up to half of patients who become infected. In the first half of 2012, nearly 200 hospitals and acute care facilities treated at least one patient for the lethal "superbug" known as CRE, according to new data from the U.S. Centers for Disease Control and Prevention. Dr. Tom Frieden, director of the CDC, called CRE a "nightmare bacteria" because of its high mortality rate, its resistance to nearly all antibiotics and its ability to spread its drug resistance to other bacteria that otherwise would be vulnerable to vaccines.
- As Medicare Advantage Cuts Loom, Disagreement Over Program's Stability
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows
- Doctors Feel Pressure to Accept Risk-based Reimbursement
- A Fresh Look at End-of-Life Care
- 3 in 4 Patients Want E-mail Consultations
- Heart Attack Patient Costs Skyrocket Beyond 30 Days
- ACGME Chief Sees 'Huge' Risk of Error in Proposed Assistant Physician Licensure
- 3 Insider Tips on Cutting Costs without Strangling Growth
- Centralizing the Revenue Cycle Protects the Bottom Line
- 4 Tectonic Shifts Shaking Up Healthcare